As of 2025-07-18, the EV/EBITDA ratio of Healthia Ltd (HLA.AX) is
7.54.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HLA.AX's latest enterprise value
is 420.72 mil AUD. HLA.AX's TTM EBITDA according to its financial statements is
55.81 mil AUD. Dividing these 2
quantities gives us the above HLA.AX EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
7.2x - 9.0x |
7.8x |
| Forward P/E multiples |
11.4x - 13.2x |
12.0x |
| Fair Price |
1.18 - 2.34 |
1.61 |
| Upside |
-34.1% - 30.6% |
-10.4% |